Physician profile

Thomas Ross Smith

Interventional Cardiology · Monroe, LA

NPI 1972895282

$14,048.84

in general payments reported to CMS, 2019-2025

34 companies · $2,211 in 2025

The $2,211 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$4,049.04
Travel and Lodging$1,972.71
Education$20.22

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbott Laboratories $4,485.42 2019-2025 Aveir, Advisor, Assurity
Boston Scientific Corporation $2,404.77 2019-2025 Watchman Access System, Watchman
Edwards Lifesciences Corporation $1,373.33 2019-2024 Edwards Sapien 3 Transcatheter Heart Valve (Thv)
Novartis Pharmaceuticals Corporation $1,122.61 2019-2025
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $903.53 2019-2025 Lifevest
Inari Medical, INC. $716.00 2022-2024 Flowtriever Catheter, S, Ct Thrombectomy System Kit
Janssen Pharmaceuticals, INC $556.04 2021-2024 Xarelto
Abiomed $397.46 2021-2025 Impella
Medtronic, INC. $315.55 2021-2024 Corevalve Evolut R, Onyx Frontier
Itamar Medical INC $267.76 2022-2023 Watchpatone
Merck Sharp & Dohme LLC $213.49 2021-2025 Verquvo
Zoll Respicardia, INC. $173.40 2024 Remede System
Shockwave Medical, INC $170.56 2025
Pfizer INC. $123.80 2022-2024
Scpharmaceuticals INC. $86.19 2024-2025
Show all 34 companies
CompanyGeneral paymentsYearsTop products
Bayer Healthcare Pharmaceuticals INC. $83.21 2025
Boehringer Ingelheim Pharmaceuticals, INC. $78.75 2022-2025 Jardiance
Regeneron Healthcare Solutions, INC. $72.10 2024-2025 Dupixent
Novo Nordisk INC $60.46 2024-2025 Wegovy
Sanofi-Aventis U.S. LLC $59.65 2021-2024
Irhythm Technologies, INC. $52.48 2023 Zio Xt Patch
Inspire Medical Systems, INC. $50.82 2025 Inspire
E.R. Squibb & Sons, L.L.C. $50.50 2022-2023
Lexicon Pharmaceuticals, INC. $34.36 2023 Inpefa
Kiniksa Pharmaceuticals, LTD. $30.69 2023 Arcalyst
Stryker Corporation $27.57 2025 Flowtriever Catheter, S, Ct Thrombectomy System Kit
Acutus Medical, INC. $26.47 2020
Viatris Specialty LLC $25.21 2025 Yupelri
Philips North America LLC $22.69 2025 Lm Undivided
Medtronic Vascular, INC. $19.17 2020
Amgen INC. $15.02 2025 Repatha
Glaxosmithkline, LLC. $12.46 2019
Cardiovascular Systems INC. $11.52 2021
Zoll Circulation INC $5.80 2023 Downstream Cartridge, Catheter, Therox Ds2 Console

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Thomas Ross Smith

$14,048.84

in general payments reported 2019-2025

Years
2019-2025
Top company
Abbott Laboratories
Context
The $2,211 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).

https://glasscript.com/doctor/1383204/thomas-ross-smith

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.